TOREMIFENE for Breast cancer recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where TOREMIFENE was used for Breast cancer recurrent.
Most Reported Side Effects for TOREMIFENE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 19 | 7.8% | 0 | 7 |
| Drug ineffective | 17 | 6.9% | 3 | 3 |
| General physical health deterioration | 14 | 5.7% | 1 | 13 |
| Atrial fibrillation | 13 | 5.3% | 0 | 12 |
| Nausea | 12 | 4.9% | 0 | 3 |
| Endometrial hyperplasia | 10 | 4.1% | 0 | 3 |
| Hepatic function abnormal | 10 | 4.1% | 0 | 4 |
| Oedema peripheral | 10 | 4.1% | 0 | 8 |
| Drug-induced liver injury | 9 | 3.7% | 0 | 3 |
| Endometrial thickening | 9 | 3.7% | 0 | 4 |
| Myelosuppression | 9 | 3.7% | 0 | 6 |
| Pyrexia | 9 | 3.7% | 0 | 8 |
| Asthenia | 8 | 3.3% | 0 | 4 |
| Pain | 8 | 3.3% | 0 | 5 |
| Product use issue | 8 | 3.3% | 1 | 2 |
Other Indications for TOREMIFENE
Breast cancer (114)
Product used for unknown indication (37)
Invasive ductal breast carcinoma (17)
Breast cancer metastatic (15)
Desmoid tumour (6)
Other Drugs Used for Breast cancer recurrent
ERIBULIN (346)
PALBOCICLIB (318)
ABEMACICLIB (298)
EVEROLIMUS (180)
LETROZOLE (163)
TRASTUZUMAB (157)
FULVESTRANT (155)
PACLITAXEL (124)
DOCETAXEL (111)
PERTUZUMAB (95)